Healthcare professionals should consider alternatives to Tygacil in patients with severe infections.
Entries Tagged as 'FDA Alerts'
Tygacil (tigecycline): Label Change - Increased Mortality Risk
September 1st, 2010 · No Comments
Tags: FDA · FDA Alerts
Huber Needles: Recall - Risk of Coring
August 26th, 2010 · No Comments
Risk of infection, damage or death of tissue, swelling, or other serious adverse health consequences occurring as a result of the core travelling through blood vessels into the patient’s lungs.
Tags: FDA · FDA Alerts
Fingerstick Devices to Obtain Blood Specimens: Initial Communication - Risk of Transmitting Bloodborne Pathogens
August 26th, 2010 · No Comments
Increase in reports of bloodborne infection transmission resulting from the shared use of fingerstick and point-of-care blood testing devices.
Tags: FDA · FDA Alerts
TimeOut Capsules: Undeclared Drug Ingredient
August 25th, 2010 · No Comments
Product marketed as dietary supplement contains undeclared hydroxythiohomosildenafil, a chemical similar to sildenafil, which may interact with nitrates found in some prescription drugs and lower blood pressure to dangerous levels.
Tags: FDA · FDA Alerts
Octagam [Immune Globulin Intravenous (human)] 5% Liquid Preparation: Market Withdrawal - Risk of Thromboembolic Events
August 25th, 2010 · No Comments
Customers asked to immediately quarantine the use of affected lots due to the potential for serious thromboembolic events.
Tags: FDA · FDA Alerts